AMINOSYN-PF 10% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aminosyn-pf 10%, and when can generic versions of Aminosyn-pf 10% launch?
Aminosyn-pf 10% is a drug marketed by Otsuka Icu Medcl and is included in one NDA.
The generic ingredient in AMINOSYN-PF 10% is amino acids. There are three hundred and fifty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aminosyn-pf 10%
A generic version of AMINOSYN-PF 10% was approved as amino acids by B BRAUN on April 13th, 2012.
US Patents and Regulatory Information for AMINOSYN-PF 10%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka Icu Medcl | AMINOSYN-PF 10% | amino acids | INJECTABLE;INJECTION | 019492-002 | Oct 17, 1986 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
